Bolzacchini Elena, Nigro Olga, Inversini Davide, Giordano Monica, Maconi Giovanni
Department of Oncology, Ospedale Sant' Anna, ASST Lariana, Como 22100, Italy, Department of Medicine and Surgery, University of Insubria, Varese 21100, Italy.
Department of Oncology, Ospedale di Circolo ASST-Sette Laghi, Varese 21100, Italy.
World J Clin Oncol. 2021 May 24;12(5):382-392. doi: 10.5306/wjco.v12.i5.382.
Intestinal metastases from breast cancer (BC) arerare; available data depend mainly on case reports and case series.
To conduct a review of the literature regarding presentation, diagnosis, treatment and survival of patients with intestinal metastasis from BC.
We identified all articles that described patients with intestinal metastasis (from duodenum to anum) from BC using MEDLINE (1975 to 2020) and EMBASE (1975 to 2020) electronic databases.
We found 96 cases of intestinal metastasis of BC. Metastasization involved large bowel (cecum, colon, sigmoid, rectum) (51%), small bowel (duodenum, jejunum, ileum) (49%), and anum (< 1%). Median age of patients was 61-years. The most frequent histology was infiltrating lobular carcinoma followed by infiltrating ductal carcinoma. In more than half of patients, the diagnosis was made after the diagnosis of BC (median: 7.2 years) and in many cases of emergency, for bowel obstruction, bleeding or perforation. Diagnosis was achieved through endoscopy, radiological examination or both. In most of the cases, patients underwent surgery with or without systemic therapies. Survival of patients included in this review was available in less than 50% of patients and showed an overall median of 12 mo since diagnosis of the intestinal metastasis.
Although, intestinal metastases of BC are considered a rare condition, clinicians should consider the possibility of intestinal involvement in case of abdominal symptoms even in acute setting and many years after the diagnosis of BC, especially in patients with a histology of lobular carcinoma.
乳腺癌(BC)的肠转移很少见;现有数据主要依赖于病例报告和病例系列研究。
对有关BC肠转移患者的临床表现、诊断、治疗及生存情况的文献进行综述。
我们使用MEDLINE(1975年至2020年)和EMBASE(1975年至2020年)电子数据库,检索了所有描述BC肠转移(从十二指肠至肛门)患者的文章。
我们发现了96例BC肠转移病例。转移累及大肠(盲肠、结肠、乙状结肠、直肠)(51%)、小肠(十二指肠、空肠、回肠)(49%)和肛门(<1%)。患者的中位年龄为61岁。最常见的组织学类型是浸润性小叶癌,其次是浸润性导管癌。超过一半的患者是在BC诊断之后(中位时间:7.2年)确诊的,且在许多急诊情况下,是因肠梗阻、出血或穿孔而确诊。诊断通过内镜检查、放射学检查或两者结合来实现。在大多数病例中,患者接受了手术,有的还接受了全身治疗。本综述纳入患者的生存情况在不到50%的患者中可用,自肠转移诊断以来的总体中位生存期为12个月。
尽管BC的肠转移被认为是一种罕见情况,但临床医生即使在急性情况下以及BC诊断多年后,尤其是组织学类型为小叶癌的患者出现腹部症状时,也应考虑肠道受累的可能性。